BICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS
Disclosed are compounds of Formula (I) or a salt or prodrug thereof, wherein: X is C or N; Y is C or N; Z is CR4 or N; provided that when: (i) X is N, then Y is C; and (ii) X is C, then Y is N and Z is N; and wherein R1, R2, R3, and R4 are define herein. Also disclosed are methods of using such comp...
Saved in:
| Main Authors | , , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
01.12.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Disclosed are compounds of Formula (I) or a salt or prodrug thereof, wherein: X is C or N; Y is C or N; Z is CR4 or N; provided that when: (i) X is N, then Y is C; and (ii) X is C, then Y is N and Z is N; and wherein R1, R2, R3, and R4 are define herein. Also disclosed are methods of using such compounds as modulators of IRAK4, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases, or in the treatment of cancer. |
|---|---|
| AbstractList | Disclosed are compounds of Formula (I) or a salt or prodrug thereof, wherein: X is C or N; Y is C or N; Z is CR4 or N; provided that when: (i) X is N, then Y is C; and (ii) X is C, then Y is N and Z is N; and wherein R1, R2, R3, and R4 are define herein. Also disclosed are methods of using such compounds as modulators of IRAK4, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases, or in the treatment of cancer. |
| Author | Paidi, Venkatram Reddy Hynes, John Polimera, Subba Rao Nair, Satheesh Kesavan Santella, Joseph B Wu, Hong |
| Author_xml | – fullname: Nair, Satheesh Kesavan – fullname: Santella, Joseph B – fullname: Hynes, John – fullname: Wu, Hong – fullname: Polimera, Subba Rao – fullname: Paidi, Venkatram Reddy |
| BookMark | eNrjYmDJy89L5WSwcPJ0jnT28XRW8HANcQ3ydwyK9FFw9vcN8A_1cwlWCA12dQv1UXAMVvAMcvQ2UfD08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkZGxhYGxuZGjobGxKkCACIcK0I |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US2022380372A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US2022380372A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Aug 30 05:42:34 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US2022380372A13 |
| Notes | Application Number: US202017634615 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221201&DB=EPODOC&CC=US&NR=2022380372A1 |
| ParticipantIDs | epo_espacenet_US2022380372A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20221201 |
| PublicationDateYYYYMMDD | 2022-12-01 |
| PublicationDate_xml | – month: 12 year: 2022 text: 20221201 day: 01 |
| PublicationDecade | 2020 |
| PublicationYear | 2022 |
| RelatedCompanies | BRISTOL-MYERS SQUIBB COMPANY |
| RelatedCompanies_xml | – name: BRISTOL-MYERS SQUIBB COMPANY |
| Score | 3.4429657 |
| Snippet | Disclosed are compounds of Formula (I) or a salt or prodrug thereof, wherein: X is C or N; Y is C or N; Z is CR4 or N; provided that when: (i) X is N, then Y... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| Title | BICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221201&DB=EPODOC&locale=&CC=US&NR=2022380372A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVfFRZUHJLZgmaZscgiSbhETzIg9pTyVPECQtNuLfdxJb7am33R0YZhfm8e3OzAI8ohfjpLQYsZXAFayY8jkrT1OZLdr7Qa5ECCC31ciuN7ES8WU2nvXgY1sL0_UJ_e6aI6JG5ajvTWevV_-XWHqXW7l-yt5xaflsxorObNAxj4YYsbGuKUbg6z5lKFWSiPHCjiZInDDlVcRKB20g3XbaN960ti5ltetUzFM4DJBf3ZxBr6wHcEy3f68N4MjdPHnjcKN963OQNJvOqWNTYhkYhfpqOHcI9d3ATzw9IklkmIlD1IjYofoqEtuzbM2O_TC6gAfTiKnFogiLvx0vkmhXXuES-vWyLq-AyPyoFKWKy4WsFIVJJuUFupgsxTiZT7kqu4bhPk43-8m3cNJOf7M1htBvPr_KO_S5TXbfHdUPlbd_RQ |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-Kj6oLSWzBNYpsciiSbhMTmUfKQ9lTyBEHSYiP-fSdrqz31tuzAMLswj292ZhbgEb0YLyf5gCtFPuekRMg4ZZQoXN7kB_kCIYDSdCO73tCKpdfZ86wFH9teGDYn9JsNR0SNylDfa2avV_9JLJ3VVq6f0nfcWr6Y0Vjvb9CxgIYYsbGujY2pr_u0T-k4DvtewGiizIsjQUWsdDBCUMjA0pvW9KWsdp2KeQKHU-RX1afQKqoudOj277UuHLmbJ29cbrRvfQayZtM5dWxKLAOjUF8N5g6hvjv1Y08PSRwaZuwQNSR2oE4kYnuWrdmRH4Tn8GAaEbU4FGHxd-JFHO7KK15Au1pWxSUQRRgUklzymZgWkjhM5SxHF5MmGCcLCV-mV9Dbx-l6P_keOlbkOgvH9iY3cNyQfis3etCuP7-KW_S_dXrHru0HrnGCLw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BICYCLIC+HETEROARYL+COMPOUNDS+USEFUL+AS+IRAK4+INHIBITORS&rft.inventor=Nair%2C+Satheesh+Kesavan&rft.inventor=Santella%2C+Joseph+B&rft.inventor=Hynes%2C+John&rft.inventor=Wu%2C+Hong&rft.inventor=Polimera%2C+Subba+Rao&rft.inventor=Paidi%2C+Venkatram+Reddy&rft.date=2022-12-01&rft.externalDBID=A1&rft.externalDocID=US2022380372A1 |